NPY and CGRP Inhibitor Influence on ERK Pathway and Macrophage Aggregation during Fracture Healing

Peng Tang1, Chunguang Duan1, Zheng Wang1

  • 1Department of Trauma and Orthopaedics, Xijing Hospital, the Fourth Military Medical University, Xi'an, China.

Abstract

Insights

Neuropeptide Y (NPY) and Calcitonin Gene-Related Peptide (CGRP) influence fracture healing by affecting ERK signaling and macrophage aggregation. Their levels peak around 8 weeks post-injury.

Area of Science:

  • Biomedical research
  • Molecular biology
  • Regenerative medicine

Background:

  • Fracture healing is a complex biological process.
  • The roles of specific neurotransmitters in bone repair are not fully understood.
  • ERK signaling pathway is crucial for cellular processes, including bone regeneration.

Purpose of the Study:

  • To investigate the effects of Neuropeptide Y (NPY) and Calcitonin Gene-Related Peptide (CGRP) on ERK signaling in fracture healing.
  • To determine the correlation between macrophage aggregation and the efficiency of fracture healing.

Main Methods:

  • A rat fracture model was established.
  • Neurotransmitter receptor inhibitors were administered.
  • Immunofluorescence, ELISA, Micro-CT, and Western blot were used to assess molecular and histological changes.
  • Macrophage aggregation was quantified in the injury area.

Main Results:

  • Serum levels of NPY and CGRP increased significantly during fracture healing, peaking at 8 weeks.
  • Inhibitors of NPY and CGRP impaired fracture healing and reduced phosphorylated ERK levels.
  • Macrophages expressing NPY and CGRP were observed to aggregate at the fracture site.

Conclusions:

  • NPY and CGRP play a role in fracture healing.
  • These neurotransmitters modulate phosphorylated ERK expression during bone repair.
  • Macrophage aggregation is associated with the fracture healing process.